FMP

FMP

Enter

OCX - OncoCyte Corporation

photo-url-https://images.financialmodelingprep.com/symbol/OCX.png

OncoCyte Corporation

OCX

NASDAQ

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

2.08 USD

-0.04 (-1.92%)

OCX Financial Statements

Year

2023

2022

2021

2020

Total Revenue

1.5M

958k

7.73M

1.22M

Cost of Revenue

1.09M

976k

7.54M

1.85M

Gross Profit

413k

-18k

188k

-639k

Operating Expenses

25.64M

30.31M

47.13M

33.08M

Research and Development

9.29M

7.3M

13.63M

9.8M

Selling, General & Administrative Expenses

13.54M

23.01M

33.5M

23.28M

Selling & Marketing Expenses

2.79M

1.13M

11.17M

6.49M

General & Administrative Expenses

10.74M

21.88M

22.34M

16.79M

Other Expenses

2.72M

-67k

-37k

27k

Operating Income

-25.14M

-18M

-46.95M

-29.71M

Total Other Income/Expenses Net

281k

-615k

854k

-1.48M

Income Before Tax

-24.86M

-18.61M

-73.36M

-31.19M

Income Tax

0

54.83M

-9.26M

-1.25M

Net Income

-27.78M

-73.44M

-64.1M

-29.93M

Basic EPS

-3.75

-13.26

-14.42

-9.14

EPS Diluted

-3.75

-13.26

-14.42

-9.14

Basic Average Shares

7.65M

5.54M

4.45M

3.27M

Diluted Average Shares

7.65M

5.54M

4.45M

3.27M

EBITDA

-23.12M

-13.31M

-48.46M

-30.54M

Retained Earning Schedule

Year

2023

2022

2021

2020

Retained Earnings (Previous Year)

-260.68M

-187.77M

-123.68M

-93.75M

Net Income

-27.78M

-73.44M

-64.1M

-29.93M

Stock Repurchases

-1.12M

0

-239k

-14k

Dividend Paid

0

0

0

0

Retained Earnings

-289.88M

-260.68M

-187.77M

-123.68M

Other Distributions

-30.32M

-72.9M

-64.34M

-29.95M

PPE Schedule

Year

2023

2022

2021

2020

Gross PPE

5.44M

10.85M

8.53M

6.52M

Annual Depreciation

1.68M

5.22M

4.21M

394k

Capital Expenditure

-281k

-4.34M

-2.25M

-1.23M

Net PPE

4.04M

9.97M

6.57M

7.36M

Intangible and Goodwill Schedule

Year

2023

2022

2021

2020

Acquisitions and Adjustments

0

-18.68M

9.5M

9.19M

Goodwill (Previous Year)

0

18.68M

9.19M

0

Goodwill

0

0

18.68M

9.19M

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep